Annual report
7747.TEDINET S100P9GU
Period2021-07-01 → 2022-06-30
Filed2022-09-30
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥77.7bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥61.5bn | 2020-07-01 → 2021-06-30 | Cons. | Net sales |
| Revenue | ¥56.5bn | 2019-07-01 → 2020-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥57.2bn | 2018-07-01 → 2019-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥50.1bn | 2017-07-01 → 2018-06-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥15.2bn | 2021-07-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥12.8bn | 2020-07-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥16.3bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥13.2bn | 2020-07-01 → 2021-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥12.3bn | 2019-07-01 → 2020-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥14.8bn | 2018-07-01 → 2019-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.7bn | 2017-07-01 → 2018-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥15.7bn | 2021-07-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥13.1bn | 2020-07-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥10.9bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥10.0bn | 2020-07-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥9.2bn | 2019-07-01 → 2020-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.2bn | 2018-07-01 → 2019-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥10.0bn | 2017-07-01 → 2018-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥11.0bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥10.0bn | 2020-07-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥155.1bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥115.4bn | at 2021-06-30 | Cons. | Assets |
| Total assets | ¥93.7bn | at 2020-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥84.4bn | at 2019-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥72.1bn | at 2018-06-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥34.0bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥22.5bn | at 2021-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥121.1bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥92.9bn | at 2021-06-30 | Cons. | Net assets |
| Net assets / equity | ¥72.0bn | at 2020-06-30d | Cons. | Net assets |
| Net assets / equity | ¥65.5bn | at 2019-06-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥53.6bn | at 2018-06-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥32.3bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥21.4bn | at 2021-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥32.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.4bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.6bn | at 2020-06-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.8bn | at 2019-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥17.5bn | at 2018-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥17.3bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.9bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥11.2bn | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥11.7bn | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥11.7bn | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥18.7bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥16.3bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.4bn | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥10.8bn | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥10.5bn | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥11.4bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥10.1bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥850m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥267m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.7bn | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥40.01 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.25 | 2020-07-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.25 | 2019-07-01 → 2020-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.29 | 2018-07-01 → 2019-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.88 | 2017-07-01 → 2018-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥40 | 2021-07-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥38.07 | 2020-07-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥35.07 | 2019-07-01 → 2020-06-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.02 | 2018-07-01 → 2019-06-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥38.63 | 2017-07-01 → 2018-06-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥439.8 | at 2022-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥349.18 | at 2021-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥276.13 | at 2020-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥251.37 | at 2019-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥207.34 | at 2018-06-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 77.0% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.5% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.8% | at 2020-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.6% | at 2019-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.3% | at 2018-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 10.2% | 2021-07-01 → 2022-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2020-07-01 → 2021-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.4% | 2019-07-01 → 2020-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 18.9% | 2018-07-01 → 2019-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 20.4% | 2017-07-01 → 2018-06-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 10,435 | at 2022-06-30 | Cons. | Number of employees |
| Employees | 9,409 | at 2021-06-30 | Cons. | Number of employees |
| Employees | 8,761 | at 2020-06-30d | Cons. | Number of employees |
| Employees | 7,810 | at 2019-06-30d | Cons. | Number of employees |
| Employees | 6,998 | at 2018-06-30d | Cons. | Number of employees |
| Revenue | ¥63.5bn | 2021-07-01 → 2022-06-30 | Standalone | Net sales |
| Revenue | ¥50.9bn | 2020-07-01 → 2021-06-30 | Standalone | Net sales |
| Revenue | ¥47.4bn | 2019-07-01 → 2020-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥46.1bn | 2018-07-01 → 2019-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥40.4bn | 2017-07-01 → 2018-06-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥11.0bn | 2021-07-01 → 2022-06-30 | Standalone | Operating income |
| Operating income | ¥8.2bn | 2020-07-01 → 2021-06-30 | Standalone | Operating income |
| Ordinary income | ¥13.2bn | 2021-07-01 → 2022-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥8.9bn | 2020-07-01 → 2021-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥10.0bn | 2019-07-01 → 2020-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.9bn | 2018-07-01 → 2019-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.2bn | 2017-07-01 → 2018-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥12.8bn | 2021-07-01 → 2022-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥8.8bn | 2020-07-01 → 2021-06-30 | Standalone | Income before income taxes |
| Net income | ¥9.5bn | 2021-07-01 → 2022-06-30 | Standalone | Profit loss |
| Net income | ¥6.7bn | 2020-07-01 → 2021-06-30 | Standalone | Profit loss |
| Net income | ¥7.9bn | 2019-07-01 → 2020-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.9bn | 2018-07-01 → 2019-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.3bn | 2017-07-01 → 2018-06-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥120.9bn | at 2022-06-30 | Standalone | Assets |
| Total assets | ¥91.4bn | at 2021-06-30 | Standalone | Assets |
| Total assets | ¥71.3bn | at 2020-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥60.9bn | at 2019-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥53.5bn | at 2018-06-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥34.7bn | at 2022-06-30 | Standalone | Liabilities |
| Total liabilities | ¥24.2bn | at 2021-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥86.2bn | at 2022-06-30 | Standalone | Net assets |
| Net assets / equity | ¥67.2bn | at 2021-06-30 | Standalone | Net assets |
| Net assets / equity | ¥49.6bn | at 2020-06-30d | Standalone | Net assets |
| Net assets / equity | ¥44.1bn | at 2019-06-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥36.2bn | at 2018-06-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥23.0bn | at 2022-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥8.3bn | at 2021-06-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥35.09 | 2021-07-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.8 | 2020-07-01 → 2021-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.32 | 2019-07-01 → 2020-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.51 | 2018-07-01 → 2019-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.32 | 2017-07-01 → 2018-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥35.08 | 2021-07-01 → 2022-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥25.68 | 2020-07-01 → 2021-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.16 | 2019-07-01 → 2020-06-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.32 | 2018-07-01 → 2019-06-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥28.13 | 2017-07-01 → 2018-06-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥11.99 | 2021-07-01 → 2022-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥11.26 | 2020-07-01 → 2021-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥8.81 | 2019-07-01 → 2020-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥21.61 | 2018-07-01 → 2019-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19.43 | 2017-07-01 → 2018-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥317.39 | at 2022-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥252.48 | at 2021-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥190.43 | at 2020-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥169.61 | at 2019-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥139.91 | at 2018-06-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 71.3% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.4% | at 2021-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.6% | at 2020-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.5% | at 2019-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.5% | at 2018-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 12.4% | 2021-07-01 → 2022-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.5% | 2020-07-01 → 2021-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.8% | 2019-07-01 → 2020-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.7% | 2018-07-01 → 2019-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.1% | 2017-07-01 → 2018-06-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 271,633,600 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 265,972,800 | at 2021-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 260,561,600 | at 2020-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 130,134,000 | at 2019-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 129,241,600 | at 2018-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,041 | at 2022-06-30 | Standalone | Number of employees |
| Employees | 925 | at 2021-06-30 | Standalone | Number of employees |
| Employees | 875 | at 2020-06-30d | Standalone | Number of employees |
| Employees | 755 | at 2019-06-30d | Standalone | Number of employees |
| Employees | 666 | at 2018-06-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 57
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2021-07-01 → 2022-06-30 | ¥261m |
| Reconciling Itemsreconciling | depreciation | 2021-07-01 → 2022-06-30 | ¥280m |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2022-06-30 | −¥13.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2022-06-30 | −¥13.9bn |
| Reconciling Itemsreconciling | segment assets | at 2022-06-30 | ¥17.1bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-06-30 | −¥4.1bn |
| Devicereportable segment | capex | 2021-07-01 → 2022-06-30 | ¥3.0bn |
| Devicereportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥2.4bn |
| Devicereportable segment | employees | at 2022-06-30 | 3400 pure |
| Devicereportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥23.3bn |
| Devicereportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥9.4bn |
| Devicereportable segment | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥13.9bn |
| Devicereportable segment | segment assets | at 2022-06-30 | ¥33.5bn |
| Devicereportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥5.3bn |
| Medicalreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥5.7bn |
| Medicalreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥3.7bn |
| Medicalreportable segment | employees | at 2022-06-30 | 6482 pure |
| Medicalreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥68.3bn |
| Medicalreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥68.3bn |
| Medicalreportable segment | segment assets | at 2022-06-30 | ¥104.5bn |
| Medicalreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥14.1bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-07-01 → 2022-06-30 | ¥8.7bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-07-01 → 2022-06-30 | ¥6.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2022-06-30 | ¥91.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2022-06-30 | ¥77.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥13.9bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-06-30 | ¥138.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2022-06-30 | ¥19.4bn |
| Reconciling Itemsreconciling | capex | 2020-07-01 → 2021-06-30 | ¥1.6bn |
| Reconciling Itemsreconciling | depreciation | 2020-07-01 → 2021-06-30 | ¥346m |
| Reconciling Itemsreconciling | revenue | 2020-07-01 → 2021-06-30 | −¥5.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2020-07-01 → 2021-06-30 | −¥5.9bn |
| Reconciling Itemsreconciling | segment assets | at 2021-06-30 | ¥15.8bn |
| Reconciling Itemsreconciling | segment profit | 2020-07-01 → 2021-06-30 | −¥4.3bn |
| Devicereportable segment | capex | 2020-07-01 → 2021-06-30 | ¥6.0bn |
| Devicereportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥1.3bn |
| Devicereportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥14.1bn |
| Devicereportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥8.4bn |
| Devicereportable segment | revenue intersegment | 2020-07-01 → 2021-06-30 | ¥5.7bn |
| Devicereportable segment | segment assets | at 2021-06-30 | ¥23.6bn |
| Devicereportable segment | segment profit | 2020-07-01 → 2021-06-30 | ¥3.3bn |
| Medicalreportable segment | capex | 2020-07-01 → 2021-06-30 | ¥4.1bn |
| Medicalreportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥3.1bn |
| Medicalreportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥53.3bn |
| Medicalreportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥53.1bn |
| Medicalreportable segment | revenue intersegment | 2020-07-01 → 2021-06-30 | ¥249m |
| Medicalreportable segment | segment assets | at 2021-06-30 | ¥76.0bn |
| Medicalreportable segment | segment profit | 2020-07-01 → 2021-06-30 | ¥13.7bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-07-01 → 2021-06-30 | ¥10.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-07-01 → 2021-06-30 | ¥4.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-07-01 → 2021-06-30 | ¥67.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-07-01 → 2021-06-30 | ¥61.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-07-01 → 2021-06-30 | ¥5.9bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-06-30 | ¥99.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-07-01 → 2021-06-30 | ¥17.0bn |
| Devicereportable segment | employees | at 2022-06-30 | 285 pure |
| Medicalreportable segment | employees | at 2022-06-30 | 639 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,525
| Item | Context | Value | Unit |
|---|---|---|---|
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000MiyataKenjiMember | 1970-07-16 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02349-000MiyataKenjiMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000MiyataKenjiMember | Original text (Japanese)注４ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000KatoTadakazuMember | Original text (Japanese)専務取締役メディカル事業統括本部長 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000KatoTadakazuMember | Original text (Japanese)加藤 忠和 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000KatoTadakazuMember | 1954-07-25 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02349-000KatoTadakazuMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000KatoTadakazuMember | Original text (Japanese)注４ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000MatsumotoMunechikaMember | Original text (Japanese)常務取締役基盤技術研究本部長 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000MatsumotoMunechikaMember | Original text (Japanese)松本 宗近 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000MatsumotoMunechikaMember | 1954-11-16 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02349-000MatsumotoMunechikaMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000MatsumotoMunechikaMember | Original text (Japanese)注４ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000TeraiYoshinoriMember | Original text (Japanese)取締役新規事業開発本部長兼メディカル事業統括本部ブランドビジネスユニット海外営業・マーケティング統括 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000TeraiYoshinoriMember | Original text (Japanese)寺井 芳徳 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000TeraiYoshinoriMember | 1963-09-13 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02349-000TeraiYoshinoriMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000TeraiYoshinoriMember | Original text (Japanese)注４ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000ItoMizuhoMember | Original text (Japanese)取締役管理本部長兼経営戦略室長 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000ItoMizuhoMember | Original text (Japanese)伊藤 瑞穂 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000ItoMizuhoMember | 1973-09-08 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02349-000ItoMizuhoMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000ItoMizuhoMember | Original text (Japanese)注４ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000NishiuchiMakotoMember | Original text (Japanese)取締役メディカル事業統括本部ブランドビジネスユニット長 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000NishiuchiMakotoMember | Original text (Japanese)西内 誠 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000NishiuchiMakotoMember | 1964-08-15 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02349-000NishiuchiMakotoMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000NishiuchiMakotoMember | Original text (Japanese)注４ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000ItoKiyomichiMember | Original text (Japanese)取締役 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000ItoKiyomichiMember | Original text (Japanese)伊藤 清道 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000ItoKiyomichiMember | 1950-02-07 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02349-000ItoKiyomichiMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000ItoKiyomichiMember | Original text (Japanese)注４ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000KusakariTakahiroMember | Original text (Japanese)取締役 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000KusakariTakahiroMember | Original text (Japanese)草刈 貴弘 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000KusakariTakahiroMember | 1979-03-14 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02349-000KusakariTakahiroMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000KusakariTakahiroMember | Original text (Japanese)注４ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000TomidaRyujiMember | Original text (Japanese)取締役(監査等委員である取締役) | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000TomidaRyujiMember | Original text (Japanese)富田 隆司 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000TomidaRyujiMember | 1975-04-03 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02349-000TomidaRyujiMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000TomidaRyujiMember | Original text (Japanese)注５ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000HananoYasunariMember | Original text (Japanese)取締役(監査等委員である取締役) | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000HananoYasunariMember | Original text (Japanese)花野 康成 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000HananoYasunariMember | 1964-04-28 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02349-000HananoYasunariMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000HananoYasunariMember | Original text (Japanese)注５ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000FukayaRyoukoMember | Original text (Japanese)取締役(監査等委員である取締役) | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02349-000FukayaRyoukoMember | Original text (Japanese)深谷 玲子 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |